Adlai Nortye (ANL) Debt Ratio (2022 - 2025)
Adlai Nortye (ANL) reported Debt Ratio of 0.71 for Q4 2025, up 93.24% year-over-year from 0.37 in Q4 2024, and up 16.75% on a QoQ basis from 0.61 in Q2 2025.
Adlai Nortye (ANL) has 4 years of Debt Ratio data on file, last reported at 0.71 in Q4 2025.
- Quarterly Debt Ratio rose 93.24% year-over-year to 0.71 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.71 (up 93.24% YoY) and the FY2025 annual result came in at 0.71, up 93.24% from the prior year.
- Debt Ratio climbed to 0.71 in Q4 2025 per ANL's latest filing, from 0.61 in the prior quarter.
- Across five years, Debt Ratio topped out at 0.71 in Q4 2025 and bottomed at 0.06 in Q4 2022.
- The 4-year median for Debt Ratio is 0.37 (2024), against an average of 0.39.
- The widest annual swing landed in 2023, when Debt Ratio jumped 293.02%; it then jumped 58.44% in 2024.
- Tracing ANL's Debt Ratio over 4 years: stood at 0.06 in 2022, then jumped by 293.02% to 0.23 in 2023, then jumped by 58.44% to 0.37 in 2024, then soared by 93.24% to 0.71 in 2025.
- Per Business Quant, the three latest ANL Debt Ratio figures stand at 0.71 (Q4 2025), 0.61 (Q2 2025), and 0.37 (Q4 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,638,563.89 Bn | 1,638,563.89 Bn | - | - |
| 2 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - | - |
| 3 | Legend Biotech | 2,937.00 Bn | 2,936.10 Bn | 242.10 Mn | 0.18 |
| 4 | Nanobiotix | 2,282.79 Bn | 2,282.72 Bn | - | 1.41 |
| 5 | Akari Therapeutics | 2,169.69 Bn | 2,169.69 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.41 Bn | 103.16 Bn | 2.59 Bn | - |
| 7 | Regeneron Pharmaceuticals | 66.44 Bn | 57.69 Bn | 3.31 Bn | 0.05 |
| 8 | Evaxion A | 65.44 Bn | 65.42 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.53 Bn | 36.52 Bn | 959.66 Mn | - |
| 10 | Adlai Nortye | 23,840.00 | -8.03 Mn | - | 0.71 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.71 |
| Jun 30, 2025 | 0.61 |
| Dec 31, 2024 | 0.37 |
| Jun 30, 2024 | 0.36 |
| Dec 31, 2023 | 0.23 |
| Dec 31, 2022 | 0.06 |